STAAR Surgical PE Ratio 2010-2023 | STAA

Current and historical p/e ratio for STAAR Surgical (STAA) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. STAAR Surgical PE ratio as of May 13, 2024 is 79.91.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

STAAR Surgical PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-05-13 43.57 101.33
2023-12-31 31.21 $0.43 72.58
2023-09-30 40.18 $0.39 103.03
2023-06-30 52.57 $0.50 105.14
2023-03-31 63.95 $0.64 99.92
2022-12-31 48.54 $0.78 62.23
2022-09-30 70.55 $0.76 92.83
2022-06-30 70.93 $0.67 105.87
2022-03-31 79.91 $0.58 137.78
2021-12-31 91.30 $0.49 186.33
2021-09-30 128.53 $0.46 279.41
2021-06-30 152.50 $0.42 363.10
2021-03-31 105.41 $0.22 479.14
2020-12-31 79.22 $0.12 660.17
2020-09-30 56.56 $0.19 297.68
2020-06-30 61.54 $0.16 384.63
2020-03-31 32.26 $0.27 119.48
2019-12-31 35.17 $0.30 117.23
2019-09-30 25.78 $0.18 143.22
2019-06-30 29.38 $0.16 183.63
2019-03-31 34.19 $0.12 284.92
2018-12-31 31.91 $0.10 319.10
2018-09-30 48.00 $0.08 600.00
2018-06-30 31.00 $0.08 387.50
2018-03-31 14.80 $0.02 740.00
2017-12-31 15.50 $-0.04 0.00
2017-09-30 12.45 $-0.04 0.00
2017-06-30 10.80 $-0.11 0.00
2017-03-31 9.80 $-0.14 0.00
2016-12-31 10.85 $-0.29 0.00
2016-09-30 9.40 $-0.31 0.00
2016-06-30 5.51 $-0.31 0.00
2016-03-31 7.39 $-0.30 0.00
2015-12-31 7.14 $-0.16 0.00
2015-09-30 7.76 $-0.21 0.00
2015-06-30 9.66 $-0.24 0.00
2015-03-31 7.43 $-0.25 0.00
2014-12-31 9.11 $-0.23 0.00
2014-09-30 10.63 $-0.18 0.00
2014-06-30 16.80 $-0.10 0.00
2014-03-31 18.80 $-0.04 0.00
2013-12-31 16.19 $0.01 0.00
2013-09-30 13.54 $-0.01 0.00
2013-06-30 10.15 $-0.02 0.00
2013-03-31 5.63 $-0.04 0.00
2012-12-31 6.10 $-0.04 0.00
2012-09-30 7.56 0 0.00
2012-06-30 7.77 0 0.00
2012-03-31 10.83 $0.03 361.00
2011-12-31 10.49 $0.03 349.67
2011-09-30 7.80 $0.01 780.00
2011-06-30 5.30 $-0.02 0.00
2011-03-31 5.57 $-0.09 0.00
2010-12-31 6.10 $0.00 0.00
2010-09-30 5.41 $-0.25 0.00
2010-06-30 5.72 $-0.28 0.00
2010-03-31 3.82 $-0.27 0.00
2009-12-31 3.10 $-0.43 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.081B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.780B 20.42
Becton Dickinson (BDX) United States $68.110B 19.27
West Pharmaceutical Services (WST) United States $26.529B 47.54
Cardinal Health (CAH) United States $24.242B 13.86
Align Technology (ALGN) United States $20.454B 39.49
Cooper (COO) United States $18.834B 28.50
Labcorp (LH) United States $17.507B 15.07
Henry Schein (HSIC) United States $9.419B 16.70
DENTSPLY SIRONA (XRAY) United States $5.791B 14.99
Merit Medical Systems (MMSI) United States $4.697B 25.74
Patterson (PDCO) United States $2.267B 10.86
CONMED (CNMD) United States $2.192B 19.88
Atrion (ATRI) United States $0.784B 41.86
Lifevantage (LFVN) United States $0.085B 10.98
Pro-Dex (PDEX) United States $0.064B 32.09
Biolase (BIOL) United States $0.006B 0.00